BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,020,211 | -34.3% | 80,052 | -17.3% | 0.00% | -50.0% |
Q2 2023 | $6,115,612 | +36.4% | 96,766 | -2.9% | 0.00% | +100.0% |
Q1 2023 | $4,484,289 | -24.1% | 99,673 | -26.1% | 0.00% | -50.0% |
Q4 2022 | $5,908,130 | +854.5% | 134,858 | +1334.7% | 0.00% | – |
Q3 2022 | $619,000 | -63.2% | 9,400 | -71.7% | 0.00% | -100.0% |
Q2 2022 | $1,680,000 | -45.6% | 33,248 | -31.2% | 0.00% | 0.0% |
Q1 2022 | $3,086,000 | -55.2% | 48,303 | -24.9% | 0.00% | -50.0% |
Q4 2021 | $6,889,000 | +27.2% | 64,321 | +22.0% | 0.00% | 0.0% |
Q3 2021 | $5,418,000 | +199.0% | 52,704 | +155.8% | 0.00% | +100.0% |
Q2 2021 | $1,812,000 | -71.4% | 20,603 | -68.4% | 0.00% | -50.0% |
Q1 2021 | $6,331,000 | +219.3% | 65,113 | +268.3% | 0.00% | +100.0% |
Q4 2020 | $1,983,000 | +288.8% | 17,677 | +221.5% | 0.00% | – |
Q3 2020 | $510,000 | -25.3% | 5,499 | -37.2% | 0.00% | – |
Q2 2020 | $683,000 | +187.0% | 8,753 | +115.3% | 0.00% | – |
Q1 2020 | $238,000 | -87.8% | 4,066 | -83.3% | 0.00% | -100.0% |
Q4 2019 | $1,952,000 | -55.7% | 24,366 | -59.3% | 0.00% | -50.0% |
Q3 2019 | $4,403,000 | +8207.5% | 59,930 | +10601.8% | 0.00% | – |
Q2 2019 | $53,000 | +96.3% | 560 | +67.2% | 0.00% | – |
Q1 2019 | $27,000 | -98.5% | 335 | -99.0% | 0.00% | -100.0% |
Q4 2018 | $1,841,000 | +3.3% | 34,134 | +49.4% | 0.00% | 0.0% |
Q3 2018 | $1,783,000 | -75.0% | 22,846 | -79.7% | 0.00% | -66.7% |
Q2 2018 | $7,135,000 | +36.9% | 112,390 | +97.8% | 0.00% | +50.0% |
Q1 2018 | $5,210,000 | +305.4% | 56,818 | +233.4% | 0.00% | +100.0% |
Q4 2017 | $1,285,000 | -44.8% | 17,044 | -49.0% | 0.00% | 0.0% |
Q3 2017 | $2,330,000 | +101.2% | 33,435 | +46.4% | 0.00% | 0.0% |
Q2 2017 | $1,158,000 | +295.2% | 22,841 | +211.7% | 0.00% | – |
Q1 2017 | $293,000 | -18.6% | 7,328 | -42.9% | 0.00% | – |
Q4 2016 | $360,000 | +267.3% | 12,829 | +287.0% | 0.00% | – |
Q3 2016 | $98,000 | +69.0% | 3,315 | +14.3% | 0.00% | – |
Q2 2016 | $58,000 | -63.3% | 2,900 | -67.0% | 0.00% | – |
Q1 2016 | $158,000 | -29.1% | 8,801 | +3.9% | 0.00% | – |
Q4 2015 | $223,000 | +25.3% | 8,472 | +1.4% | 0.00% | – |
Q3 2015 | $178,000 | -14.0% | 8,351 | +6.7% | 0.00% | – |
Q2 2015 | $207,000 | – | 7,825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |